These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19622001)

  • 21. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 2):47-60. PubMed ID: 9618323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of CYP4A expression by bezafibrate in primary culture of rat and human hepatocytes: interspecies difference and influence of N-acetylcysteine.
    Alvergnas M; Richert L; Blanchard N; Abadie C; Heyd B; Mantion G; Gallemann D; Martin H
    Toxicol In Vitro; 2009 Oct; 23(7):1259-67. PubMed ID: 19647067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance.
    Wiemann C; Goettel M; Vardy A; Elcombe BM; Elcombe CR; Chatham LR; Wang H; Li L; Buesen R; Honarvar N; Treumann S; Marxfeld H; Groeters S; Lake BG
    Toxicology; 2019 Oct; 426():152282. PubMed ID: 31465819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of CYP2B induction in the liver of rats and mice by different compounds.
    Pustylnyak VO; Lebedev AN; Gulyaeva LF; Lyakhovich VV; Slynko NM
    Life Sci; 2007 Jan; 80(4):324-8. PubMed ID: 17045615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY; Shin HS; Bae SK; Lee MG
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation.
    Deguchi Y; Yamada T; Hirose Y; Nagahori H; Kushida M; Sumida K; Sukata T; Tomigahara Y; Nishioka K; Uwagawa S; Kawamura S; Okuno Y
    Toxicol Sci; 2009 Mar; 108(1):69-80. PubMed ID: 19176366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrition and enzyme inducers in liver tumor promotion in human and rat.
    McLean EM; Driver H; McDanell R
    Bull Cancer; 1990; 77(5):505-8. PubMed ID: 2400825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species differences in response to the phthalate plasticizer monoisononylphthalate (MINP) in vitro: a comparison of rat and human hepatocytes.
    Shaw D; Lee R; Roberts RA
    Arch Toxicol; 2002 Jun; 76(5-6):344-50. PubMed ID: 12107652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model.
    Li D; Yang XL; Zhang SJ; Lin M; Yu WJ; Hu K
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jan; 147(1):17-29. PubMed ID: 17826359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin.
    Okuda Y; Kushida M; Kikumoto H; Nakamura Y; Higuchi H; Kawamura S; Cohen SM; Lake BG; Yamada T
    J Toxicol Sci; 2017; 42(6):773-788. PubMed ID: 29142176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism.
    Yamada H; Ishii Y; Yamamoto M; Oguri K
    Curr Drug Metab; 2006 May; 7(4):397-409. PubMed ID: 16724929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of constitutive and inducible ethoxyresorufin-O-deethylase activity in the liver of suckermouth armored catfish (Hypostomus affinis and Hypostomus auroguttatus, Loricariidae).
    Parente TE; De-Oliveira AC; Beghini DG; Chapeaurouge DA; Perales J; Paumgartten FJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):252-60. PubMed ID: 19460462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse.
    Kondo M; Miyata K; Nagahori H; Sumida K; Osimitz TG; Cohen SM; Lake BG; Yamada T
    Toxicol Sci; 2019 Apr; 168(2):572-596. PubMed ID: 30629241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Evaluation of the Human Relevance of the Liver Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action.
    Kondo M; Kikumoto H; Osimitz TG; Cohen SM; Lake BG; Yamada T
    Toxicol Sci; 2020 May; 175(1):50-63. PubMed ID: 32040184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolism of 2,2',4,5,5'-pentachlorobiphenyl (CB101) by liver microsomes of rats, hamsters and guinea pigs].
    Ohta C; Matsuoka M; Haraguchi K; Kato Y; Endo T; Koga N
    Fukuoka Igaku Zasshi; 2007 May; 98(5):236-44. PubMed ID: 17642303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.
    Lake BG
    Toxicol Res (Camb); 2018 Jul; 7(4):697-717. PubMed ID: 30090615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites.
    Zawaira A; Matimba A; Masimirembwa C
    Pharmacogenet Genomics; 2008 Jun; 18(6):467-76. PubMed ID: 18496126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice.
    Alnouti Y; Klaassen CD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):612-21. PubMed ID: 17993606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental sleep by non-barbiturate hypnotics and modifiers of hepatic microsome activity].
    Boismare F; Camacho M; Lechat P
    Therapie; 1969; 24(6):949-54. PubMed ID: 5367189
    [No Abstract]   [Full Text] [Related]  

  • 40. Human health risk assessment for peroxisome proliferators: more than 30 years of research.
    Fidaleo M
    Exp Toxicol Pathol; 2009 May; 61(3):215-21. PubMed ID: 18926675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.